IDXX Q4 2023 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$902M+8.8% YoY

Gross Profit

$526M58.4% margin

Operating Income

$245M27.2% margin

Net Income

$195M21.6% margin

EPS (Diluted)

$2.32

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$250M

Free Cash Flow

$217M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.8B

Stockholders' Equity

$1.5B

Cash & Equivalents

$454M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$902M	$829M	+8.8%
Gross Profit	$526M	$485M	+8.5%
Operating Income	$245M	$227M	+8.3%
Net Income	$195M	$172M	+13.0%

Revenue Segments

Product

$1.0B57%

Service

$774M43%

Geographic Segments

UNITED STATES

$576M57%

Asia Pacific

$186M19%

EMEA

$184M18%

CANADA

$37M4%

Latin America

$22M2%